In the midst of the political cacophony that perpetually surrounds us, a disquieting narrative has begun to take shape once again. With the looming specter of the upcoming election, it seems that the familiar shadow of COVID-19 is being resurrected from the depths of our collective memory. Whispers of a new variant have crept into our consciousness, prompting Joe Biden to seek additional funding for Big Pharma and an updated vaccine. Concurrently, the media drums up stories of rising COVID hospitalizations, and prominent figures, including Jill Biden, suddenly find themselves ensnared by the virus. (glonme.com) The message reverberates: brace yourself for the resurgence of COVID-19, for it has not released its grip on our lives. But should this be the sole source of our trepidation?
Recall the tumultuous days of the pandemic when we placed our faith in vaccines as a beacon of hope, only to discover that they didn’t necessarily provide an impenetrable shield against the virus. Doubts grew, skepticism festered, and the very definition of a vaccine underwent a transformation, shedding references to immunity. As discussions of an updated vaccine persist, you may have contemplated whether it is a path you wish to tread. Yet, amid this contemplation, the notion of a new vaccine mandate floated ominously.
It appears that the Biden administration is poised to do whatever it takes to ensure a demand for this updated vaccine. This vaccine, approved by the FDA for all Americans aged six months and older, has, according to Dr. Marty Makary of Johns Hopkins, received this stamp of approval in the absence of robust human trial data. Dr. Makary lays bare the disconcerting truth, “They are telling every American six months of age and older to get this new COVID vaccine, but they approved it based on almost no data. There’s no human clinical trial data. Pfizer submitted data on ten mice. And Moderna, which also got a new vaccine approved. This is not an additional booster. This is an entirely newly designed COVID vaccine. They want everyone to get even if you had COVID a few months ago. They don’t care. They’re pushing it hard.”
What’s more, it appears that children, who have been statistically less susceptible to severe COVID-19 effects, are not immune to this push. (glonme.com) (pjmedia.com) The White House, as Dr. (glonme.com) Makary reveals, has procured four times as many doses for children this time around, raising concerns about the urgency behind this endeavor. (t.co) The data, when scrutinized, reveals a troubling event where one of the fifty participants in the Moderna trial suffered an adverse event necessitating medical attention.
Pfizer, with its dearth of human trial data, and Moderna, with its opacity regarding adverse effects, stand before us. The question looms: how can they escape the scrutiny one might expect for such critical matters of public health? (pjmedia.com) Dr. (twitter.com) Makary has an unsettling answer, “They know that the regulatory process to get this approved is totally greased. President Biden was out there saying that this thing works and everyone needs to get it before the FDA even, you know, approved it. So this thing was greased.”
Let your imagination wander to a scenario where one in fifty doses results in an adverse effect. A consequence like this, in times past, would have triggered an unequivocal rejection from the FDA. Recall, if you will, that the Biden administration enacted a pause on the Johnson & Johnson COVID vaccine due to a minuscule one-in-a-million risk of blood clots. As you weigh the evidence before you, ponder this: why, then, is the Biden Administration urging you to embrace an updated vaccine that has not undergone the rigorous testing that should precede such decisions? Why do they insist that you need protection from a virus that, by all accounts, has lost much of its previous severity?
These questions hang in the air, unanswered, as we find ourselves perched on the precipice of a consequential choice. The labyrinthine corridors of politics and healthcare intersect, leaving us, the public, to navigate a path fraught with uncertainty. As we contemplate the path ahead, let us remember that in times of uncertainty, vigilance and the pursuit of truth should be our guiding lights.
